| Current Price | $5.30 | Mkt Cap | $1.3B |
|---|---|---|---|
| Open | $5.60 | P/E Ratio | 0.00 |
| Prev. Close | $5.30 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $5.30 - $5.61 | Volume | 2,166,937 |
| 52-Wk Range | $2.50 - $5.95 | Avg. Daily Vol. | 3,467,136 |
A biotechnology company, developing technologies and products to treat cancers and infectious diseases, based on immunological approaches.
| Current Price | $5.30 | Mkt Cap | $1.3B |
|---|---|---|---|
| Open | $5.60 | P/E Ratio | 0.00 |
| Prev. Close | $5.30 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $5.30 - $5.61 | Volume | 2,166,937 |
| 52-Wk Range | $2.50 - $5.95 | Avg. Daily Vol. | 3,467,136 |
The best Bull and Bear pitches based on recency and number of recommendations.
I'm an Agenus skeptic but I think there's a good chance of a rebound ahead of topline data from the phase II trial of HerpV therapeutic herpes simplex 2 vaccine expected in Q4 2013. A good bellwether for the trial results will be if Agenus decides to… More
Read the most recent pitches from players about AGEN.
Recs
StevesStox
(29.79)
Submitted: 7/15/2021 6:01:16 AM :
Start Price:
$5.46
NASDAQ:AGEN Score:
-4.36
AGEN-1181 is the real deal.
Recs
PM7
(< 20)
Submitted: 1/24/2021 12:14:01 AM :
Start Price:
$3.47
NASDAQ:AGEN Score:
+37.89
Significant number of drugs under final stages of phase 2 and 3 trials and 2 of them likely to get FDA approval and both on FDA fast track.
Recs
rocknrook
(52.46)
Submitted: 6/27/2017 7:53:50 AM :
Start Price:
$4.01
NASDAQ:AGEN Score:
-49.29
Assuming effective test results. I like that there is significant interest from big players in partnering.
Find the members with the highest scoring picks in AGEN.
svande8952 (81.89) Score: +437.54
The Score Leader is the player with the highest score across all their picks in AGEN.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| svande8952 | 81.89 | 6/16/2009 |
|
5Y | $12.24 | -56.70% | +380.84% | +437.54 | 1 Comment | |
| 1or5stars | 99.08 | 6/8/2009 |
|
3W | $13.68 | -61.26% | +374.86% | +436.12 | 0 Comment | |
| TWreckz | 98.88 | 6/5/2009 |
|
5Y | $15.90 | -66.67% | +366.54% | +433.21 | 0 Comment | |
| rcbaldwinjr | 80.71 | 8/5/2009 |
|
3W | $13.85 | -61.74% | +344.29% | +406.04 | 0 Comment | |
| rhinomaj | < 20 | 8/4/2009 |
|
3M | $14.34 | -63.04% | +341.50% | +404.54 | 0 Comment | |
| epc53 | 26.42 | 8/7/2009 |
|
5Y | $13.26 | -60.03% | +339.00% | +399.03 | 0 Comment | |
| chop3399 | < 20 | 3/13/2008 |
|
5Y | $13.44 | -60.57% | +254.62% | +315.19 | 0 Comment | |
| JackOffBadApples | 62.14 | 9/12/2008 |
|
3W | $10.02 | -47.11% | +266.04% | +313.14 | 0 Comment | |
| ortiz176 | 53.37 | 4/14/2008 |
|
1Y | $15.48 | -65.76% | +244.97% | +310.73 | 0 Comment | |
| DayTr8der88 | < 20 | 9/22/2008 |
|
NS | $9.90 | -46.46% | +263.17% | +309.63 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
